HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheryl Lutz Selected Research

Hypersensitivity (Allergy)

7/2002Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheryl Lutz Research Topics

Disease

2Cough
10/2006 - 09/2004
2Seasonal Allergic Rhinitis (Hay Fever)
10/2006 - 09/2004
2Sneezing
02/2006 - 09/2004
2Rhinorrhea
02/2006 - 09/2004
2Allergic Rhinitis
02/2006 - 09/2004
1Hypersensitivity (Allergy)
07/2002
1Headache (Headaches)
07/2002

Drug/Important Bio-Agent (IBA)

4AllergensIBA
10/2006 - 07/2002
4fexofenadine (Allegra)FDA LinkGeneric
10/2006 - 07/2002
3PseudoephedrineFDA LinkGeneric
10/2006 - 07/2002
3Nasal Decongestants (Decongestants)IBA
10/2006 - 07/2002
2Histamine Antagonists (Antihistamines)IBA
10/2006 - 09/2004
2trans-sodium crocetinate (crocetin)IBA
10/2006 - 09/2004
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
07/2002